STAT

Insurers can profit while improving the lives of people with type 1 diabetes

Three simple changes could help insurance companies keeping people with type 1 diabetes healthier and boost their own bottom lines.

As the debate over the future of health care coverage moves in fits and starts, it may seem like any improvements in health care coverage are equally stalled. But they aren’t. Insurance companies can take action now to make immediate differences in people’s lives — especially those with type 1 diabetes.

Improving the coverage they offer can help these individuals more easily control their condition. Such changes could also benefit insurance companies — keeping people with diabetes healthier would ultimately boost their bottom lines.

Unlike type 2 diabetes, which

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks